Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy

Data on 16 potential risk factors for myelosuppression were assessed in 134 patients who received either vindesine and cisplatin (VP) or mitomycin C, vindesine and cisplatin (MVP) for inoperable stage III or IV non‐small cell lung cancer in a randomized trial. Determinant factors for myelosuppressio...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Jpn J Cancer Res
Hlavní autoři: Matsui, Kaoru, Masuda, Noriyuki, Uchida, Yasuo, Fukuoka, Masahiro, Negoro, Shunichi, Yana, Takashi, Kusunoki, Yoko, Kudoh, Shinzoh, Kawase, Ichiro, Kawahara, Masaaki, Ogawara, Mitsumasa, Kodama, Nagahisa, Kubota, Kaoru, Furuse, Kiyoyuki
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 1996
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921149/
https://ncbi.nlm.nih.gov/pubmed/8698630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1996.tb00292.x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky